HALEY DECKER: Open Payments
NPI 1760107411 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 11 payments from 8 companies in 2025. Trend: 2023 $1,077 · 2024 $584 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $66 |
| Exeltis, USA Inc. | 2 | $35 |
| MILLICENT US INC | 1 | $28 |
| Astellas Pharma US Inc | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| Organon LLC | 1 | $19 |
Products named: MYFEMBREE, SLYND, FEMLYV, Veozah, Kyleena, MOUNJARO, Wegovy, NEXPLANON.
Industry payments across NY — which companies pay providers there.
